Preliminary investigations focused on biodistribution of polymeric nanoparticles (NPs) shortly after ultrasound-guided delivery via the portal vein in early second-trimester fetal rhesus monkeys. Results demonstrated that poly(lactic-co-glycolic acid) (PLGA) NPs (N = 3; 3 mg administered at 75–80 days gestational age) and poly(amine-co-ester)-polyethylene glycol (PACE-PEG) NPs (N = 3; 3 mg at 75–80 days gestational age) distributed to fetal tissues when assessed 24 h post-administration. No adverse findings were observed. PLGA NPs were found primarily in the fetal liver and spleen, whereas PACE-PEG NPs showed more widespread biodistribution to a range of anatomical sites. In another fetal subset with PACE-PEG NPs (N = 2; 90 days gestational age) assessed within 48-h post-administration, results demonstrated enhanced green fluorescent protein reporter mRNA expression in select tissues. These early-stage short-term studies suggest that polymeric NPs, particularly those composed of PACE-PEG, can be safely administered and are potential candidates for fetal delivery of therapeutic nucleic acids. While preliminary, these studies provide evidence to support further investigations in this species to address long-term safety and efficiency.
BahalR, Ali McNeerN, QuijanoE, et al.In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery. Nat Commun, 2016; 7:13304; doi: 10.1038/ncomms13304
2.
CunD, FogedC, YangM, et al.Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm, 2010; 390(1):70–75; doi: 10.1016/j.ijpharm.2009.10.023
3.
FieldsRJ, QuijanoE, McNeerNA, et al.Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung. Adv Healthc Mater, 2015; 4(3):361–366; doi: 10.1002/adhm.201400355
4.
McNeerNA, ChinJY, SchleifmanEB, et al.Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors. Mol Ther, 2011; 19(1):172–180; doi: 10.1038/mt.2010.200
5.
Piotrowski-DaspitAS, BaroneC, LinCY, et al.In vivo correction of cystic fibrosis mediated by PNA nanoparticles. Sci Adv, 2022; 8(40):eabo0522; doi: 10.1126/sciadv.abo0522
6.
LuoD, Woodrow-MumfordK, BelchevaN, et al.Controlled DNA delivery systems. Pharm Res, 1999; 16(8):1300–1308; doi: 10.1023/a:1014870102295
7.
LvH, ZhangS, WangB, et al.Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release, 2006; 114(1):100–109; doi: 10.1016/j.jconrel.2006.04.014
8.
MonneryBD, WrightM, CavillR, et al.Cytotoxicity of polycations: Relationship of molecular weight and the hydrolytic theory of the mechanism of toxicity. Int J Pharm, 2017; 521(1–2):249–258; doi: 10.1016/j.ijpharm.2017.02.048
9.
PackDW, HoffmanAS, PunS, et al.Design and development of polymers for gene delivery. Nat Rev Drug Discov, 2005; 4(7):581–593; doi: 10.1038/nrd1775
10.
CuiJ, Piotrowski-DaspitAS, ZhangJ, et al.Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver. J Control Release, 2019; 304:259–267; doi: 10.1016/j.jconrel.2019.04.044
11.
JiangY, LuQ, WangY, et al.Quantitating endosomal escape of a library of polymers for mRNA delivery. Nano Lett, 2020; 20(2):1117–1123; doi: 10.1021/acs.nanolett.9b04426
12.
KauffmanAC, Piotrowski-DaspitAS, NakazawaKH, et al.Tunability of biodegradable Poly(amine-co-ester) polymers for customized nucleic acid delivery and other biomedical applications. Biomacromolecules, 2018; 19(9):3861–3873; doi: 10.1021/acs.biomac.8b00997
13.
Piotrowski-DaspitAS, BracagliaLG, EatonDA, et al.Enhancing in vivo cell and tissue targeting by modulation of polymer nanoparticles and macrophage decoys. Nat Commun, 2024; 15(1):4247; doi: 10.1038/s41467-024-48442-7
14.
ZhouJ, LiuJ, ChengCJ, et al.Biodegradable Poly(amine-co-ester) terpolymers for targeted gene delivery. Nat Mater, 2011; 11(1):82–90; doi: 10.1038/nmat3187
15.
HarrisJM, ChessRB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov, 2003; 2(3):214–221; doi: 10.1038/nrd1033
16.
Piotrowski-DaspitAS, KauffmanAC, BracagliaLG, et al.Polymeric vehicles for nucleic acid delivery. Adv Drug Deliv Rev, 2020; 156:119–132; doi: 10.1016/j.addr.2020.06.014
17.
ShiL, ZhangJ, ZhaoM, et al.Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale, 2021; 13(24):10748–10764; doi: 10.1039/d1nr02065j
18.
MorenoA, PitocGA, GansonNJ, et al.Anti-PEG antibodies inhibit the anticoagulant activity of PEGylated aptamers. Cell Chem Biol, 2019; 26(5):634–644.e3; doi: 10.1016/j.chembiol.2019.02.001
19.
GrunMK, SuberiA, ShinK, et al.PEGylation of poly(amine-co-ester) polyplexes for tunable gene delivery. Biomaterials, 2021; 272:120780; doi: 10.1016/j.biomaterials.2021.120780
20.
CullisPR, FelgnerPR. The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nat Rev Drug Discov, 2024; 23(9):709–722; doi: 10.1038/s41573-024-00977-6
21.
TarantalAF, NoctorSC, Hartigan-O’ConnorDJ. Nonhuman primates in translational research. Annu Rev Anim Biosci, 2022; 10:441–468; doi: 10.1146/annurev-animal-021419-083813
22.
TarantalAF. Chapter 20: Ultrasound imaging in rhesus (Macaca mulatta) and long-tailed (Macaca fascicularis) macaques: Reproductive and research applications. In: The Laboratory Primate. (Woolf-CooteS., eds.) Elsevier; 2005; pp. 317–351.
23.
ParkJK, UtsumiT, SeoYE, et al.Cellular distribution of injected PLGA-nanoparticles in the liver. Nanomedicine, 2016; 12(5):1365–1374; doi: 10.1016/j.nano.2016.01.013
24.
JimenezDF, LeeCI, O’SheaCE, et al.HIV-1-derived lentiviral vectors and fetal route of administration on transgene biodistribution and expression in rhesus monkeys. Gene Ther, 2005; 12(10):821–830; doi: 10.1038/sj.gt.3302464
25.
TarantalAF, McDonaldRJ, JimenezDF, et al.Intrapulmonary and intramyocardial gene transfer in rhesus monkeys: Safety and efficiency of lentiviral vectors for fetal gene delivery. Mol Ther, 2005; 12(1):87–98; doi: 10.1016/j.ymthe.2005.01.019
26.
AlbertC, BracagliaL, KoideA, et al.Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications. Nat Commun, 2022; 13(1):5998; doi: 10.1038/s41467-022-33490-8
27.
BracagliaLG, Piotrowski-DaspitAS, LinCY, et al.High-throughput quantitative microscopy-based half-life measurements of intravenously injected agents. Proc Natl Acad Sci U S A, 2020; 117(7):3502–3508; doi: 10.1073/pnas.1915450117
28.
MandlHK, QuijanoE, SuhHW, et al.Optimizing biodegradable nanoparticle size for tissue-specific delivery. J Control Release, 2019; 314:92–101; doi: 10.1016/j.jconrel.2019.09.020
29.
MisslickKA, BaldeschwielerJD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci USA, 1996; 93(22):12349–12354; doi: 10.1073/pnas.93.22.12349
30.
JiangY, GaudinA, ZhangJ, et al.A “top-down” approach to actuate poly(amine-co-ester) terpolymers for potent and safe mRNA delivery. Biomaterials, 2018; 176:122–130; doi: 10.1016/j.biomaterials.2018.05.043
31.
DegorsIMS, WangC, RehmanZU, et al.Carriers break barriers in drug delivery: Endocytosis and endosomal escape of gene delivery vectors. Acc Chem Res, 2019; 52(7):1750–1760; doi: 10.1021/acs.accounts.9b00177
32.
NamvarA, BolhassaniA, KhairkhahN, et al.Physicochemical properties of polymers: An important system to overcome the cell barriers in gene transfection. Biopolymers, 2015; 103(7):363–375; doi: 10.1002/bip.22638
33.
XuE, SaltzmanWM, Piotrowski-DaspitAS. Escaping the endosome: Assessing cellular trafficking mechanisms of non-viral vehicles. J Control Release, 2021; 335:465–480; doi: 10.1016/j.jconrel.2021.05.038
34.
LeeCC, JimenezDF, KohnDB, et al.Fetal gene transfer using lentiviral vectors and the potential for germ cell transduction in rhesus monkeys (Macaca mulatta). Hum Gene Ther, 2005; 16(4):417–425; doi: 10.1089/hum.2005.16.417
35.
TarantalAF, SkarlatosSI. Center for Fetal Monkey Gene Transfer for Heart, Lung, and Blood Diseases: An NHLBI resource for the gene therapy community. Hum Gene Ther, 2012; 23(11):1130–1135; doi: 10.1089/hum.2012.178
36.
TarantalAF, LeeCC. Long-term luciferase expression monitored by bioluminescence imaging after adeno-associated virus-mediated fetal gene delivery in rhesus monkeys (Macaca mulatta). Hum Gene Ther, 2010; 21(2):143–148; doi: 10.1089/hum.2009.126
37.
SahaK, SontheimerEJ, BrooksPJ, et al.; SCGE Consortium. The NIH somatic cell genome editing consortium. Nature, 2021; 592(7853):195–204; doi: 10.1038/s41586-021-03191-1
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
